Viewing Study NCT03228602


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-03-03 @ 4:29 AM
Study NCT ID: NCT03228602
Status: TERMINATED
Last Update Posted: 2022-06-09
First Post: 2017-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impaired Gustatory Sensory Perception in Obese and Obese Diabetic Persons
Sponsor: Centre Hospitalier Universitaire Dijon
Organization:

Study Overview

Official Title: Gustatory Evoked Potentials and Cerebral Control of Food Intake in Obese Subjects
Status: TERMINATED
Status Verified Date: 2022-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: lack of inclusion
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PEGASE
Brief Summary: The aim of the study is to compare several parameters in three distinct groups of subjects: persons with obesity, persons with obesity and diabetes and persons with neither obesity nor diabetes:

* the electrical activity in response to a sweet solution, measured before and after a standard meal, using gustatory evoked potentials (recording explained below)
* blood hormone levels related to weight gain (insulin, dopamine, ghrelin, leptin: measured in blood samples)
* levels of activity and quantity of an enzyme present in the saliva, amylase, which is able to break down ingested starch into several molecules of glucose.

All of these parameters will be correlated to determine whether the results are different in the 3 groups of subjects in the study.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: